ASO Author Reflections: Vasohibin-1 as a Biomarker for Chemotherapeutic Response in Patients with Advanced Bladder Cancer

Affiliations

• ¹ Department of Urology, Keio University School of Medicine, Tokyo, Japan.
• ² Department of Urology, Keio University School of Medicine, Tokyo, Japan. takemduro@gmail.com.
• ³ Department of Urology, Kawasaki Municipal Hospital, Kanagawa, Japan.
• ⁴ Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan.
• ⁵ Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
• ⁶ Division of Gene Regulation, Institute for Advanced Medical Research, Graduate School of Medicine, Keio University, Tokyo, Japan.
• ⁷ Department of Vascular Biology, Institute of Development, Aging and Cancer, Tohoku University, Miyagi, Japan.